Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study-Reference-Cited by-同舟云学术

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Published:2010-10-27 Issue:1 Volume:13 Page:132-142
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Bogdahn U.,Hau P.,Stockhammer G.,Venkataramana N. K.,Mahapatra A. K.,Suri A.,Balasubramaniam A.,Nair S.,Oliushine V.,Parfenov V.,Poverennova I.,Zaaroor M.,Jachimczak P.,Ludwig S.,Schmaus S.,Heinrichs H.,Schlingensiepen K.- H.,

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/13/1/132/6391633/noq142.pdf

Reference33 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Temozolomide in the treatment of recurrent malignant glioma

4. Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials;Journal of Neuro-Oncology;2024-09-04

2. The roles and mechanisms of coding and noncoding RNA variations in cancer;Experimental & Molecular Medicine;2024-09-02

3. Structure, unique biological properties, and mechanisms of action of transforming growth factor β;Bioorganic Chemistry;2024-09

4. Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches;Human Cell;2024-07-31

5. A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma;Pharmaceuticals;2024-07-23